Cellectar Biosciences, Inc. Quarterly Current Ratio in % from Q1 2012 to Q1 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cellectar Biosciences, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q1 2024.
  • Cellectar Biosciences, Inc. Current Ratio for the quarter ending March 31, 2024 was 149 %, a 53.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 149 -170 -53.3% Mar 31, 2024
Q4 2023 117 -313 -72.8% Dec 31, 2023
Q3 2023 170 -370 -68.5% Sep 30, 2023
Q2 2023 231 -542 -70.1% Jun 30, 2023
Q1 2023 319 -702 -68.8% Mar 31, 2023
Q4 2022 430 -713 -62.4% Dec 31, 2022
Q3 2022 539 -776 -59% Sep 30, 2022
Q2 2022 773 -343 -30.7% Jun 30, 2022
Q1 2022 1.02K +42.4 +4.34% Mar 31, 2022
Q4 2021 1.14K +361 +46.2% Dec 31, 2021
Q3 2021 1.32K +841 +177% Sep 30, 2021
Q2 2021 1.12K +646 +137% Jun 30, 2021
Q1 2021 979 +524 +115% Mar 31, 2021
Q4 2020 782 +261 +49.9% Dec 31, 2020
Q3 2020 474 -138 -22.5% Sep 30, 2020
Q2 2020 471 -188 -28.6% Jun 30, 2020
Q1 2020 455 -82.9 -15.4% Mar 31, 2020
Q4 2019 522 +17.9 +3.56% Dec 31, 2019
Q3 2019 612 +173 +39.5% Sep 30, 2019
Q2 2019 659 +314 +91% Jun 30, 2019
Q1 2019 538 +108 +25.1% Mar 31, 2019
Q4 2018 504 -30.9 -5.78% Dec 31, 2018
Q3 2018 439 -160 -26.7% Sep 30, 2018
Q2 2018 345 -314 -47.7% Jun 30, 2018
Q1 2018 430 -231 -35% Mar 31, 2018
Q4 2017 535 +139 +35.3% Dec 31, 2017
Q3 2017 598 +416 +228% Sep 30, 2017
Q2 2017 659 +545 +478% Jun 30, 2017
Q1 2017 661 +588 +810% Mar 31, 2017
Q4 2016 395 +311 +367% Dec 31, 2016
Q3 2016 183 +76.3 +71.7% Sep 30, 2016
Q2 2016 114 -31.4 -21.6% Jun 30, 2016
Q1 2016 72.6 -70.7 -49.3% Mar 31, 2016
Q4 2015 84.7 -53.4 -38.7% Dec 31, 2015
Q3 2015 106 -6.91 -6.1% Sep 30, 2015
Q2 2015 145 +64 +78.6% Jun 30, 2015
Q1 2015 143 +49.9 +53.4% Mar 31, 2015
Q4 2014 138 +35.6 +34.7% Dec 31, 2014
Q3 2014 113 -24 -17.5% Sep 30, 2014
Q2 2014 81.4 -97.1 -54.4% Jun 30, 2014
Q1 2014 93.5 -212 -69.4% Mar 31, 2014
Q4 2013 103 -758 -88.1% Dec 31, 2013
Q3 2013 137 -835 -85.9% Sep 30, 2013
Q2 2013 178 -712 -79.9% Jun 30, 2013
Q1 2013 305 -473 -60.8% Mar 31, 2013
Q4 2012 861 Dec 31, 2012
Q3 2012 973 Sep 30, 2012
Q2 2012 890 Jun 30, 2012
Q1 2012 779 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.